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MISREPRESENTATION OF THE NATIONAL WOMEN’S HOSPITAL IN 
AUCKLAND, NEW ZEALAND 
The article “The Rationalization of Unethical Research” by Paul and Brookes refers to a 
study of rural sharecroppers with syphilis in Tuskegee, Alabama, and a study of women with 
cervical carcinoma in situ (CIS) in Auckland, New Zealand.
 1
 We show here that the article 
draws invalid parallels between these two situations and misrepresents what happened in 
Auckland, as did the 1988 judicial inquiry into the management of CIS at the National 
Women’s Hospital in Auckland—the Cartwright Inquiry, for which Paul was an adviser. 
The fundamental difference between the Tuskegee syphilis study and the management of 
CIS at Auckland’s National Women’s Hospital has been pointed out previously.2 In 
Tuskegee, treatment known to be effective and safe (penicillin) was unethically withheld 
from patients with syphilis; in Auckland, no treatment known to be effective and safe was 
unethically withheld from women with CIS. 
The introduction of Papanicolaou smears in the 1950s led to an explosion of diagnoses of 
CIS and to differences of opinion about how to manage the condition, contrary to Paul and 
Brookes’ claim that there was no dispute about management of CIS by the 1960s. The range 
of management strategies reflected the fact that an estimated 90% to 95% of women 
presenting with CIS would not develop invasive cancer: invasive management thus carried a 
substantial risk of overtreatment with interventions (hysterectomy and cone biopsy) that 
could have serious adverse effects. Using hysterectomy as a treatment entails not only the 
immediate complications of a major surgical procedure, but also an end to a woman’s hopes 
of having (further) children. Cone biopsy, although less radical, sometimes causes substantial 
morbidity from bleeding and infection in the short term, and increases the likelihood of a 
second trimester miscarriage in the longer term. Debate about appropriate management of 
CIS, which existed from the 1950s and was not subjected to any controlled trials, as noted by 
Professor Cochrane in the 1970s, continues today; there is still no obviously superior surgical 
technique for treating cervical intraepithelial neoplasia in terms of treatment failures or 
operative morbidity.
3
 The situation could hardly be more different from penicillin treatment 
of syphilis. 
Paul and Brookes’ article misrepresents the management of CIS at Auckland’s National 
Women’s Hospital, where gynecologist Herbert Green was particularly concerned about the 
dangers of overtreatment of the condition in the 1960s. In 1966 he proposed to the Hospital 
Medical Committee that he and his colleagues should manage CIS conservatively in women 
referred to the hospital, using careful follow-up and avoiding unnecessary surgical 
intervention. The minutes of the meeting at which this new management protocol was agreed, 
record that, “If at any stage concern was felt for the safety of the patient, a cone biopsy would 
be performed.” Like gynecologist Per Kolstad, the author of a long-term study in Norway, 
Green stressed the importance of using the new diagnostic aid of colposcopy in managing 
cases of CIS.
4
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Paul and Brookes state incorrectly that Green attempted “to prove that CIS is not a pre-
malignant disease.”1(p.e13) In support, they cite the minutes of the 1966 meeting reproduced in 
the Cartwright Report, neglecting to point to the extended discussion in the Cartwright Report 
as to whether the word “invariably” (i.e., that CIS was not invariably a premalignant disease) 
had inadvertently been omitted from the minutes of the meeting.
4
 Green made his views clear 
in his own publications, for instance writing in 1966: “These then are still the two uncertain 
factors—the length of the pre-invasive phase and the proportion going on to invasion. 
Clinical evidence is tending to show, but cannot prove that the latter is small–probably much 
less than 10 per cent.” In other articles (1969 and 1970), he again addressed the current state 
of knowledge and the uncertainty as to whether “the invasive potential in in situ cancer is as 
high as has been claimed.” In addressing this uncertainty, he was following authorities such 
as George Knox, Professor of Social Medicine at the University of Birmingham, England, 
who stated in 1966 that population and pathological evidence could suggest not one but two 
diseases—“a benign one and some hitherto unidentified lesion”; they simply did not know.5 
The role of the human papillomavirus was not identified until the 1980s. 
The treatment protocol agreed in 1966 was not a research project; there were to be no 
controls, and patients were to be treated and monitored case-by-case by one of the four 
gynecological teams at the hospital. Green audited the results of the treatment regimen by 
drawing on hospital data, and the first long-term analysis of cases diagnosed with CIS at the 
hospital was published by staff members McIndoe et al. in 1984,
6
 two years after Green had 
retired. If women were not told this conservative treatment was other than “conventional” 
(for instance, in the 1960s, hysterectomy was still a common response in the United States), 
this was in keeping with the mores of the day, when informed consent was not the norm and 
it was assumed that “the therapeutic relationship would automatically predominate over the 
scientist-subject relationship.” Evidence provided at the time of the Cartwright Inquiry 
suggested that Green kept his patients more informed about their options than did many of his 
contemporaries in New Zealand and elsewhere,
 
despite the claim made by Paul and Brookes, 
without any supporting evidence that Green “misled” his patients.” (1 p.e.2)  
Paul and Brookes erroneously state that a 1984 scientific article from the hospital
7
 
published “the results of Green’s study.”1(p.e16) McIndoe et al. had assembled data from 
women presenting at the hospital between 1955 and 1976 with a diagnosis of CIS (and seen 
by any one, but generally several, of the hospital’s medical staff), and divided them 
retrospectively into two groups: one with women whose abnormal cytology had resolved and 
the other with women whose cytology remained abnormal two years after the initial 
diagnosis.
6
 In a 1987 article that sparked the Cartwright Inquiry, the authors misinterpreted 
the 1984 article as presenting a prospective and randomized study carried out by Green of 
alternative treatment strategies rather than a retrospective study by McIndoe et al. This 
misrepresentation persisted in the Cartwright Report, and has allowed such a flawed 
comparison with Tuskegee to be made. 
Paul and Brookes are not the first to attempt to liken the inappropriately designated 
“Unfortunate Experiment” to Tuskegee and the Nazis. A similar suggestion was published six 
years ago in the Health Research Council of New Zealand’s online Ethics Notes by another 
staff member from Paul and Brookes’ own institution.8 Four of us responded in letters 
published on the HRC Web site (for these and other references, see the supplement to the 
online version of this article at http://www.ajph.org). Remarkably, Paul and Brookes make no 
reference to this earlier debate; indeed they imply there has been no debate when they state, 
“It would be wrong to exaggerate the importance of the new defenses.”1(p.e12) As references to 
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published responses contributed by us and others make abundantly clear, this is a gross 
misrepresentation. Readers who wish to make their own judgments need not take our account 
on trust: we have cited the published references in support of our account, so that people can 
decide for themselves. 
M.|A.|H. (“Tony”) Baird, MBChB 
Norman Barlev, MBChB 
Linda Bryder, DPhil 
Amanda Burls, MSc 
Robin W. Carrell, MBChB, ScD, PhD 
Iain Chalmers, DSc 
Garth J.|S. Cooper BSc (Hum Bio), MB ChB, Dip Obs, DPhil 
Derek A. Dow, PhD 
Kevin Hicks, PhD 
Marc Keirse, MD 
Colin Mantell, MBChB, PhD 
Peter Nobbs, MBChB 
Elizabeth Overton 
Helen Overton MBChB 
Paul Patten, MBChB 
Josie Sandercock, BA MSC 
     Valerie Smith 
Ronald Trubuhovich, BDS, MBChB 
ABOUT THE AUTHORS 
M.|A.|H. (“Tony”) Baird is with Auckland Urogynaecology, Auckland, New Zealand. 
Norman Barlev, is specialist anesthetist,  Denmark. Linda Bryder is Professor of History, the 
University of Auckland, New Zealand. Amanda Burls is Professor of Public Health, City 
University, London, UK. Robin W. Carrell is Emeritus Professor of Hematology, University 
of Cambridge, Cambridge, UK. Iain Chalmers is Co-founder of The Cochrane Collaboration 
and Coordinator of the James Lind Initiative, Oxford, UK. GJS Cooper is a Professor in 
Discovery and Experimental Medicine, Faculty of Medical and Health Sciences, and 
Director, Centre for Advanced Discovery and Experimental Therapeutics, University of 
Manchester, Manchester, UK. Derek A. Dow is Honorary Senior Lecturer, University of 
Publisher: APHA; Journal: AJPH:American Journal of Public Health; 
Copyright: , ; Volume: 106; Issue: 8; Manuscript: 201515358; Month: August; Year: 2016 
DOI: 10.2105/AJPH.2016.303162; TOC Head: ; Section Head:  
Article Type: LETTERS AND RESPONSES; Collection Codes: , , , , ,  
Page 4 of 4 
Auckland. Kevin Hicks is Senior Research Fellow, the Auckland Cancer Society Research 
Centre, University of Auckland. Marc Keirse is Professor and Head of Department of 
Obstetrics and Gynecology, Flinders University, Adelaide, Australia. Colin Mantell is 
Emeritus Professor of Obstetrics and Gynecology, University of Auckland. Peter Nobbs is a 
neonatal pediatrician, Auckland. Elizabeth Overton, Auckland. Helen Overton is a general 
practitioner, New Zealand and Denmark. Paul Patten is an obstetrician and gynecologist, 
Auckland. Josie Sandercock is a medical statistician, Birmingham, UK. Valerie Smith is an 
independent researcher, Dannevirke, New Zealand. Ronald Trubuhovich is a retired intensive 
care specialist, Auckland. 
Correspondence should be sent to Tony Baird, Birthcare Building, 20 Titoki St 
Parnell, Auckland 1052, New Zealand (e-mail: tonybaird@xtra.co.nz). Reprints can be 
ordered online at http://www.ajph.org by clicking the “Reprints” link. 
This letter was accepted February 25, 2016. 
 doi:10.2105.2016.303162 
CONTRIBUTORS 
All authors contributed equally to this letter. 
REFERENCES 
1. Paul C, Brookes B. The rationalization of unethical research: revisionist accounts of the 
Tuskegee Syphilis Study and the New Zealand “Unfortunate Experiment.” Am J Public 
Health. 2015;105(10):e12–e19. 
2. Chalmers I. Defendants of the Cartwright Inquiry are unable to provide a description of 
“adequate care” for cervical carcinoma in situ. N Z Med J. 2010; 123(1322):85-87. 
3. Martin-Hirsch PPL, Paraskevaidis E, Bryant A, Dickinson HO. Surgery for cervical 
intraepithelial neoplasia. Cochrane Database Syst Rev. 2013;12:CD001318. 
4. The report of the Committee of Inquiry into Allegations Concerning the Treatment of 
Cervical Cancer at National Women’s Hospital and into Other Related Matters, 22. 
Available at: 
http://www.moh.govt.nz/notebook/nbbooks.nsf/0/64D0EE19BA628E4FCC256E450001
CC21?OpenDocument. Accessed April 6, 2016. 
5. Knox EG. Cervical cytology: a scrutiny of the evidence. In: McLachlan G, ed. Problems 
and Progress in Medical Care: Essays on Current Research, Second Series. London, UK: 
Nuffield Provincial Hospitals Trust, Oxford University Press; 1966:293. 
7. McIndoe WA, McLean MR, Jones RW, Mullins PR. The invasive potential of carcinoma 
in situ of the cervix. Obstet Gynecol. 1984;66:451–458. 
8. Tolich M, Flanagan PG. New Zealanders can learn about themselves when comparing the 
“Unfortunate Experiment” with both the Tuskegee Syphilis Trial and the Nuremberg 
Code. Ethics Notes November. 2009. Available at: 
http://ndhadeliver.natlib.govt.nz/delivery/DeliveryManagerServlet?dps_pid=IE1368880&
dps_custom_att_1=ilsdb. Accessed February 3, 2016. 
